Aβ	Beta-amyloid peptides
AD	Alzheimer’s disease
AMD	Age-related macular degeneration
aROC	Area under the receiver operator characteristic
APOE	Apolipoprotein E
APP	Amyloid precursor protein
CNS	Central nervous system
CS	Contrast sensitivity
CSF	Cerebrospinal fluid
DPT	Digital Perception Test
EMA	European Medicines Agency
ETDRS	Early Treatment Diabetic Retinopathy Study
FDA	Food and Drug Administration
FDT	Frequency Doubling Technology
FH+	Familiar history positive
18F-FDG-PET	Fluorine-18 fluorodeoxyglucose positron emission tomography
LGN	Lateral geniculate nucleus
MCI	Mild cognitive impairment
MMSE	Mini-Mental State Examination
M pathway	Magnocellular pathway
MoCA	Montreal Cognitive Assessment
MRI	Magnetic Resonance Imaging
MT1	Melatonin receptor 1a
NFT	Neurofibrillary tangles
OCT	Optical Coherence Tomography
P pathway	Parvocellular pathway
PET	Positron emission tomography
PIB-PET	Pittsburgh compound B positron emission tomography
PSEN 1	Presenilin 1
PSEN 2	Presenilin 2
RCG	Retinal ganglion cells
RNFL	Retinal nerve fiber layer
ROS	Reactive oxygen species
V1	Primary visual cortex
V2	Secondary visual cortex
VA	Visual acuity
VF	Visual field